Figure 2.

Different approaches used for in vivo delivery of siRNAs. Approaches I and III are exclusively based on chemically synthesized molecules. Whereas the approach II relies on synthetic siRNAs and biologically produced hybrid proteins. This approach could be adapted to deliver siRNAs into specific cell types by exploiting cell surface receptors unique to each cell type.